BioGentech

BioGentech Co., Ltd. is a South Korean biotechnology company specializing in advanced in vitro diagnostics (IVD), with a core focus on molecular and immunodiagnostic technologies. The company has developed a proprietary integrated platform capable of diagnosing diverse conditions, including sepsis and various blood cancers, on a single system. BioGentech gained significant international recognition for its rapid development of high-accuracy PCR-based diagnostic kits for COVID-19 and monkeypox. In 2022, the company entered into a strategic partnership and investment agreement with PHC to expand its research capabilities and global distribution network. Its technology emphasizes high-sensitivity detection of genetic and protein biomarkers to facilitate early disease diagnosis and clinical decision-making.